News-Medical.Net March 18, 2025
A first-of-its-kind artificial intelligence (AI)-based neural network can rapidly analyze and interpret millions of cells from a patient sample, predicting molecular changes in the tissue. It can potentially pinpoint where personalized treatments could be most effective for conditions such as cancer.
NicheCompass leverages the power of generative AI to create a visual database combining spatial genomic data on cell types, where they are found, and how they communicate. Created by researchers at the Wellcome Sanger Institute, the Institute of AI for Health at Helmholtz Munich, the University of Würzburg, and their collaborators as part of the wider Human Cell Atlas Initiative, this is the first AI method capable of measuring and interpreting a range of data from a cell’s social...
Today's Sponsors
Today's Sponsor